BioCentury
ARTICLE | Company News

Management tracks

August 24, 2016 7:00 AM UTC

Cancer company BeiGene Ltd. (NASDAQ:BGNE) named Amy Peterson CMO of immuno-oncology, replacing interim CMO Eric Hedrick. Peterson was VP of clinical development at Medivation Inc. (NASDAQ:MDVN), which Pfizer Inc. (NYSE:PFE) is acquiring. Hedrick will continue to oversee BeiGene's hematology programs and serve as an advisor to the company.

Mitochondrial medicine company NeuroVive Pharmaceutical AB (SSE:NVP; Pink:NEVPF) said COO Jan Nilsson is leaving the company. NeuroVive said the position is no longer needed following a reorganization. ...